NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
将 長澤
Tohoku University - Sendai / Japan
Medical and Health Sciences / Nephrology
AD Scientific Index ID: 4304277
東北大学
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
将 長澤's MOST POPULAR ARTICLES
1-)
Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular riskS Ito, T Nagasawa, M Abe, T MoriHypertension Research 32 (2), 115-121, 20092362009
2-)
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese ratsJD Imig, KA Walsh, MAH Khan, T Nagasawa, MC Shaw, SM Shaw, ...Experimental Biology and Medicine 237 (12), 1402-1412, 2012622012
3-)
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trialPK Judge, N Staplin, KJ Mayne, C Wanner, JB Green, SJ Hauske, ...The Lancet Diabetes & Endocrinology 12 (1), 51-60, 2024492024
4-)
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trialN Staplin, R Haynes, PK Judge, C Wanner, JB Green, J Emberson, ...The Lancet Diabetes & Endocrinology 12 (1), 39-50, 2024462024
5-)
Kidney biopsy guidebook 2020 in JapanY Ubara, T Kawaguchi, T Nagasawa, K Miura, T Katsuno, T Morikawa, ...Clinical and experimental nephrology 25, 325-364, 2021382021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept